https://m2.mtmt.hu/ hun 2026-09-23 04:23 JournalArticle 34824221 VALIDATED true 0 false 2026-09-17T09:47:51.312+0000 2026-06-10T09:36:30.726+0000 2024-04-28T10:30:11.779+0000 true 10025780 Ostorházi Eszter /api/author/10025780 Author Ostorházi Eszter (mikrobiológus) true 10025780 2026-09-17T09:44:06.473+0000 2026-09-17T09:44:06.473+0000 2024-12-11T11:36:22.831+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Gere Tamásné (SE_KK_Admin5_GT, admin) true 10062062 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Monyók, Ádám true true /api/journal/10003252 REVIEWED INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 true false 10003252 false 10003252 true 1661-6596 1422-0067 Journal FOREIGN 25 8 4562 4562 16 2024 It is now generally accepted that the success of antitumor therapy can be impaired by concurrent antibiotic therapy, the presence of certain bacteria, and elevated defensin levels around the tumor tissue. The aim of our current investigation was to identify the underlying changes in microbiome and defensin levels in the tumor tissue induced by different antibiotics, as well as the duration of this modification. The microbiome of the tumor tissues was significantly different from that of healthy volunteers. Comparing only the tumor samples, no significant difference was confirmed between the untreated group and the group treated with antibiotics more than 3 months earlier. However, antibiotic treatment within 3 months of analysis resulted in a significantly modified microbiome composition. Irrespective of whether Fosfomycin, Fluoroquinolone or Beta-lactam treatment was used, the abundance of Bacteroides decreased, and Staphylococcus abundance increased. Large amounts of the genus Acinetobacter were observed in the Fluoroquinolone-treated group. Regardless of the antibiotic treatment, hBD1 expression of the tumor cells consistently doubled. The increase in hBD2 and hBD3 expression was the highest in the Beta-lactam treated group. Apparently, antibiotic treatment within 3 months of sample analysis induced microbiome changes and defensin expression levels, depending on the identity of the applied antibiotic. Funding 2039922 /api/funding/2039922 Human Microbiota Study Group(0272) false true true 2024 true true true false false GOLD 2026-09-17 false http://www.mdpi.com/journal/ijms 5 0 5 5 0 5 5 4 4 4 4 4 4 5 0 0 5 5 5 5 0 2 2 Folyóiratcikk Journal Article 24 5 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 5 5 5 5 D1 false false false false 2024-05-06T06:22:43.328+0000 Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K); Idegsebészeti és Neurointervenciós Klinika (SE / AOK / K); Orvosi Mikrobiológiai Intézet (SE / AOK / I) 7 37 3 9 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 116412291 /api/authorship/116412291 Monyók, Ádám 1 0.11111111 true false false Monyók Ádám true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412292 /api/authorship/116412292 Mansour, Bassel [Mansour, Bassel (Urológia), szerző] 2 0.111 false false false Author 10088944 /api/author/10088944 Mansour Bassel (Urológia) Mansour Bassel DUPLUM true true Mansour Bassel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412293 /api/authorship/116412293 Vadnay, István 3 0.11111111 false false false Vadnay István true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412294 /api/authorship/116412294 Makra, Nóra [Makra, Nóra (genomika, biológia), szerző] Orvosi Mikrobiológiai Intézet (SE / AOK / I) 4 0.111 false false false Author 10034793 /api/author/10034793 Makra Nóra (genomika, biológia) Makra Nóra true 10034793 true Makra Nóra true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412295 /api/authorship/116412295 Dunai, Zsuzsanna A. [Dunai, Zsuzsanna (Molekuláris biológia), szerző] Orvosi Mikrobiológiai Intézet (SE / AOK / I) 5 0.111 false false false Author 10032930 /api/author/10032930 Dunai Zsuzsanna (Molekuláris biológia) Dunai Zsuzsanna true 10032930 true Dunai Zsuzsanna A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412296 /api/authorship/116412296 Nemes-Nikodém, Éva [Nemes-Nikodém, Éva (Mikrobiológia), szerző] Orvosi Mikrobiológiai Intézet (SE / AOK / I) 6 0.111 false false false Author 10044483 /api/author/10044483 Nemes-Nikodém Éva (Mikrobiológia) Nemes-Nikodém Éva true 10044483 true Nemes-Nikodém Éva true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412297 /api/authorship/116412297 Stercz, Balázs [Stercz, Balázs (mikrobiológia), szerző] Orvosi Mikrobiológiai Intézet (SE / AOK / I) 7 0.111 false false false Author 10024657 /api/author/10024657 Stercz Balázs (mikrobiológia) Stercz Balázs true 10024657 true Stercz Balázs true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412298 /api/authorship/116412298 Szabó, Dóra [Szabó, Dóra (Mikrobiológia), szerző] Idegsebészeti és Neurointervenciós Klinika (SE / AOK / K); Orvosi Mikrobiológiai Intézet (SE / AOK / I) 8 0.111 false false false Author 10003357 /api/author/10003357 Szabó Dóra (Mikrobiológia) Szabó Dóra true 10003357 true Szabó Dóra true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116412299 /api/authorship/116412299 Ostorházi, Eszter ✉ [Ostorházi, Eszter (mikrobiológus), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K); Orvosi Mikrobiológiai Intézet (SE / AOK / I) 9 0.111 false true true Author 10025780 /api/author/10025780 Ostorházi Eszter (mikrobiológus) Ostorházi Eszter true 10025780 true Ostorházi Eszter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 26097568 /api/publicationidentifier/26097568 DOI: 10.3390/ijms25084562 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3390/ijms25084562 https://doi.org/10.3390/ijms25084562 false true PublicationIdentifier 26182399 /api/publicationidentifier/26182399 WoS: 001210368300001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001210368300001 https://www.webofscience.com/wos/woscc/full-record/001210368300001 false true PublicationIdentifier 26137811 /api/publicationidentifier/26137811 Scopus: 85191634590 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85191634590 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85191634590 true true PublicationIdentifier 26137812 /api/publicationidentifier/26137812 PubMed: 38674148 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38674148 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38674148&dopt=Abstract true true SjrRating 11489344 /api/sjrrating/11489344 sjr:D1 (2024) Scopus - Organic Chemistry INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 18 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1605 /api/classificationexternal/1605 Scopus - Organic Chemistry true 1605 true D1 DIRECT true true Reference 52335980 /api/reference/52335980 1. Situm 2018: The urinary microbiome associated with bladder cancer., Sci. Rep., 8, p. 12157, DOI: 10.1038/s41598-018-29054-w 1 10.1038/s41598-018-29054-w false true Reference 52335981 /api/reference/52335981 2. Hussein 2023: The Association between the Urinary Microbiome and Bladder Cancer., Urol. Clin. North. Am., 50, p. 81, DOI: 10.1016/j.ucl.2022.09.012 2 10.1016/j.ucl.2022.09.012 false true Reference 52335982 /api/reference/52335982 3. Bi 2019: Urinary microbiota—A potential biomarker and therapeutic target for bladder cancer., J. Med. Microbiol., 68, p. 1471, DOI: 10.1099/jmm.0.001058 3 10.1099/jmm.0.001058 false true Reference 52335983 /api/reference/52335983 4. Mansour 2020: Bladder cancer-related microbiota: Examining differences in urine and tissue samples., Sci. Rep., 10, p. 11042, DOI: 10.1038/s41598-020-67443-2 4 10.1038/s41598-020-67443-2 false true Reference 52335984 /api/reference/52335984 5. Mansour, B., Monyok, A., Gajdacs, M., Stercz, B., Makra, N., Penzes, K., Vadnay, I., Szabo, D., and Ostorhazi, E. (2022). Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels. Biomedicines, 10., DOI: 10.3390/biomedicines10071758 5 10.3390/biomedicines10071758 false true Reference 52335985 /api/reference/52335985 6. Li, W.T., Iyangar, A.S., Reddy, R., Chakladar, J., Bhargava, V., Sakamoto, K., Ongkeko, W.M., and Rajasekaran, M. (2021). The Bladder Microbiome Is Associated with Epithelial-Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma. Cancers, 13., DOI: 10.3390/cancers13153649 6 10.3390/cancers13153649 false true Reference 52335986 /api/reference/52335986 7. Liu 2019: Dysbiosis signatures of the microbial profile in tissue from bladder cancer., Cancer Med., 8, p. 6904, DOI: 10.1002/cam4.2419 7 10.1002/cam4.2419 false true Reference 52335987 /api/reference/52335987 8. Pederzoli 2020: Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients., Eur. Urol. Oncol., 3, p. 784, DOI: 10.1016/j.euo.2020.04.002 8 10.1016/j.euo.2020.04.002 false true Reference 52335988 /api/reference/52335988 9. Bisacchi 2016: A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone., Curr. Med. Chem., 23, p. 520, DOI: 10.2174/0929867323666151223095839 9 10.2174/0929867323666151223095839 false true Reference 52335989 /api/reference/52335989 10. Chrysostomou 2021: Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer., Sci. Transl. Med., 13, p. eaba4627, DOI: 10.1126/scitranslmed.aba4627 10 10.1126/scitranslmed.aba4627 false true Reference 52335990 /api/reference/52335990 11. Karp, I., and Lyakhovich, A. (2022). Targeting cancer stem cells with antibiotics inducing mitochondrial dysfunction as an alternative anticancer therapy. Biochem. Pharmacol., 198., DOI: 10.1016/j.bcp.2022.114966 11 10.1016/j.bcp.2022.114966 false true Reference 52335991 /api/reference/52335991 12. Jing 2022: Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy., J. Immunother. Cancer, 10, p. e003779, DOI: 10.1136/jitc-2021-003779 12 10.1136/jitc-2021-003779 false true Reference 52335992 /api/reference/52335992 13. Li 2022: Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy., Front. Med., 16, p. 307, DOI: 10.1007/s11684-022-0927-0 13 10.1007/s11684-022-0927-0 false true Reference 52335993 /api/reference/52335993 14. Fidelle 2023: A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers., Science, 380, p. eabo2296, DOI: 10.1126/science.abo2296 14 10.1126/science.abo2296 false true Reference 52335994 /api/reference/52335994 15. Pak 2021: Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer., Front. Oncol., 11, p. 570077, DOI: 10.3389/fonc.2021.570077 15 10.3389/fonc.2021.570077 false true Reference 52335995 /api/reference/52335995 16. Beerepoot 2012: Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women., Arch. Intern. Med., 172, p. 704, DOI: 10.1001/archinternmed.2012.777 16 10.1001/archinternmed.2012.777 false true Reference 52335996 /api/reference/52335996 17. Mulder, M., Radjabzadeh, D., Hassing, R.J., Heeringa, J., Uitterlinden, A.G., Kraaij, R., Stricker, B.H., and Verbon, A. (2019). The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population. BMC Microbiol., 19., DOI: 10.1186/s12866-018-1379-1 17 10.1186/s12866-018-1379-1 false true Reference 52335997 /api/reference/52335997 18. Wang 2021: Fecal Microbiota Transplantation as an Effective Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection in a Renal Transplant Patient., Infect. Drug Resist., 14, p. 1805, DOI: 10.2147/IDR.S308308 18 10.2147/IDR.S308308 false true Reference 52335998 /api/reference/52335998 19. Xu 2020: Defensins: A Double-Edged Sword in Host Immunity., Front. Immunol., 11, p. 764, DOI: 10.3389/fimmu.2020.00764 19 10.3389/fimmu.2020.00764 false true Reference 52335999 /api/reference/52335999 20. Wiesner 2010: Antimicrobial peptides: The ancient arm of the human immune system., Virulence, 1, p. 440, DOI: 10.4161/viru.1.5.12983 20 10.4161/viru.1.5.12983 false true Reference 52336000 /api/reference/52336000 21. Ghosh 2019: Human Beta Defensins and Cancer: Contradictions and Common Ground., Front. Oncol., 9, p. 341, DOI: 10.3389/fonc.2019.00341 21 10.3389/fonc.2019.00341 false true Reference 52336001 /api/reference/52336001 22. Han, Q., Wang, R., Sun, C., Jin, X., Liu, D., Zhao, X., Wang, L., Ji, N., Li, J., and Zhou, Y. (2014). Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients. PLoS ONE, 9., DOI: 10.1371/journal.pone.0091867 22 10.1371/journal.pone.0091867 false true Reference 52336002 /api/reference/52336002 23. Adyns, L., Proost, P., and Struyf, S. (2023). Role of Defensins in Tumor Biology. Int. J. Mol. Sci., 24., DOI: 10.3390/ijms24065268 23 10.3390/ijms24065268 false true Reference 52336003 /api/reference/52336003 24. Sun 2019: Discovery and mechanisms of host defense to oncogenesis: Targeting the beta-defensin-1 peptide as a natural tumor inhibitor., Cancer Biol. Ther., 20, p. 774, DOI: 10.1080/15384047.2018.1564564 24 10.1080/15384047.2018.1564564 false true Reference 52336004 /api/reference/52336004 25. Alvarez 2018: Human beta-defensin 1 update: Potential clinical applications of the restless warrior., Int. J. Biochem. Cell Biol., 104, p. 133, DOI: 10.1016/j.biocel.2018.09.007 25 10.1016/j.biocel.2018.09.007 false true Reference 52336005 /api/reference/52336005 26. Whang 2017: MEK inhibition enhances efficacy of bacillus Calmette-Guerin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides., Oncotarget, 8, p. 53168, DOI: 10.18632/oncotarget.18230 26 10.18632/oncotarget.18230 false true Reference 52336006 /api/reference/52336006 27. Kim 2013: Human beta-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells., BJU Int., 112, p. 781, DOI: 10.1111/bju.12196 27 10.1111/bju.12196 false true Reference 52336007 /api/reference/52336007 28. Meade 2018: beta-Defensins: Farming the Microbiome for Homeostasis and Health., Front. Immunol., 9, p. 3072, DOI: 10.3389/fimmu.2018.03072 28 10.3389/fimmu.2018.03072 false true Reference 52336008 /api/reference/52336008 29. Ahn 2013: Human gut microbiome and risk for colorectal cancer., J. Natl. Cancer Inst., 105, p. 1907, DOI: 10.1093/jnci/djt300 29 10.1093/jnci/djt300 false true Reference 52336009 /api/reference/52336009 30. Parra-Grande, M., Ore-Arce, M., Martinez-Priego, L., D‘Auria, G., Rossello-Mora, R., Lillo, M., Sempere, A., Lumbreras, B., and Sanchez-Hellin, V. (2021). Profiling the Bladder Microbiota in Patients With Bladder Cancer. Front. Microbiol., 12., DOI: 10.3389/fmicb.2021.718776 30 10.3389/fmicb.2021.718776 false true Reference 52336010 /api/reference/52336010 31. Mizuhashi 2021: Skin microbiome in acral melanoma: Corynebacterium is associated with advanced melanoma., J. Dermatol., 48, p. e15, DOI: 10.1111/1346-8138.15633 31 10.1111/1346-8138.15633 false true Reference 52336011 /api/reference/52336011 32. Hasan, R., Bose, S., Roy, R., Paul, D., Rawat, S., Nilwe, P., Chauhan, N.K., and Choudhury, S. (2022). Tumor tissue-specific bacterial biomarker panel for colorectal cancer: Bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicis. Arch. Microbiol., 204., DOI: 10.1007/s00203-022-02954-2 32 10.1007/s00203-022-02954-2 false true Reference 52336012 /api/reference/52336012 33. Sheweita 2020: Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer., Mediators Inflamm., 2020, p. 4070419, DOI: 10.1155/2020/4070419 33 10.1155/2020/4070419 false true Reference 52336013 /api/reference/52336013 34. Oresta 2021: The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage., J. Urol., 205, p. 86, DOI: 10.1097/JU.0000000000001336 34 10.1097/JU.0000000000001336 false true Reference 52336014 /api/reference/52336014 35. Shannon 2006: Links between Propionibacterium acnes and prostate cancer., Future Oncol., 2, p. 225, DOI: 10.2217/14796694.2.2.225 35 10.2217/14796694.2.2.225 false true Reference 52336015 /api/reference/52336015 36. Li 2021: Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling., Gastric Cancer, 24, p. 1242, DOI: 10.1007/s10120-021-01202-8 36 10.1007/s10120-021-01202-8 false true Reference 52336016 /api/reference/52336016 37. Kavoussi 1990: Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response., J. Clin. Investig., 85, p. 62, DOI: 10.1172/JCI114434 37 10.1172/JCI114434 false true Reference 52336017 /api/reference/52336017 38. Ratliff 1988: Role of fibronectin in intravesical BCG therapy for superficial bladder cancer., J. Urol., 139, p. 410, DOI: 10.1016/S0022-5347(17)42445-1 38 10.1016/S0022-5347(17)42445-1 false true Reference 52336018 /api/reference/52336018 39. Kloskowski 2022: Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review., Front. Oncol., 12, p. 890337, DOI: 10.3389/fonc.2022.890337 39 10.3389/fonc.2022.890337 false true Reference 52336019 /api/reference/52336019 40. Chen, C., Huang, Z., Huang, P., Li, K., Zeng, J., Wen, Y., Li, B., Zhao, J., and Wu, P. (2022). Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer. BMC Microbiol., 22., DOI: 10.1186/s12866-021-02407-8 40 10.1186/s12866-021-02407-8 false true Reference 52336020 /api/reference/52336020 41. Du 2023: Human beta-defensin-3 and nuclear factor-kappa B p65 synergistically promote the cell proliferation and invasion of oral squamous cell carcinoma., Transl. Oncol., 27, p. 101582, DOI: 10.1016/j.tranon.2022.101582 41 10.1016/j.tranon.2022.101582 false true Reference 52336021 /api/reference/52336021 42. Xu 2016: Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-kappaB signaling., Oncotarget, 7, p. 75902, DOI: 10.18632/oncotarget.12426 42 10.18632/oncotarget.12426 false true Reference 52336022 /api/reference/52336022 43. Uraki 2014: Human beta-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression., Int. J. Oncol., 45, p. 1059, DOI: 10.3892/ijo.2014.2507 43 10.3892/ijo.2014.2507 false true Reference 52336023 /api/reference/52336023 44. Yan 2019: Evaluation of the CosmosID Bioinformatics Platform for Prosthetic Joint-Associated Sonicate Fluid Shotgun Metagenomic Data Analysis., J. Clin. Microbiol., 57, p. e01182-18, DOI: 10.1128/JCM.01182-18 44 10.1128/JCM.01182-18 false true Reference 52336024 /api/reference/52336024 45. Livak 2001: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method., Methods, 25, p. 402, DOI: 10.1006/meth.2001.1262 45 10.1006/meth.2001.1262 false true /api/publication/34824221 Monyók Ádám et al. Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma. (2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 25 8<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Monyók Ádám </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10088944"><a href="/gui2/?type=authors&mode=browse&sel=10088944" target="_blank">Mansour Bassel (<span class="authorship-author-name">Mansour Bassel</span> <span class="authorAux-mtmt"> Urológia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Vadnay István </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10034793"><a href="/gui2/?type=authors&mode=browse&sel=10034793" target="_blank">Makra Nóra (<span class="authorship-author-name">Makra Nóra</span> <span class="authorAux-mtmt"> genomika, biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10032930"><a href="/gui2/?type=authors&mode=browse&sel=10032930" target="_blank">Dunai Zsuzsanna A. (<span class="authorship-author-name">Dunai Zsuzsanna</span> <span class="authorAux-mtmt"> Molekuláris biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10044483"><a href="/gui2/?type=authors&mode=browse&sel=10044483" target="_blank">Nemes-Nikodém Éva (<span class="authorship-author-name">Nemes-Nikodém Éva</span> <span class="authorAux-mtmt"> Mikrobiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024657"><a href="/gui2/?type=authors&mode=browse&sel=10024657" target="_blank">Stercz Balázs (<span class="authorship-author-name">Stercz Balázs</span> <span class="authorAux-mtmt"> mikrobiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003357"><a href="/gui2/?type=authors&mode=browse&sel=10003357" target="_blank">Szabó Dóra (<span class="authorship-author-name">Szabó Dóra</span> <span class="authorAux-mtmt"> Mikrobiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Idegsebészeti és Neurointervenciós Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10025780"><a href="/gui2/?type=authors&mode=browse&sel=10025780" target="_blank">Ostorházi Eszter ✉ (<span class="authorship-author-name">Ostorházi Eszter</span> <span class="authorAux-mtmt"> mikrobiológus</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Orvosi Mikrobiológiai Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34824221" target="_blank">Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma</a></div> <div> <span class="journal-title">INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1661-6596">1661-6596</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1422-0067">1422-0067</a>)</span>: <span class="journal-volume">25</span> <span class="journal-issue">8</span> <span class="page"> Paper 4562. 16 p. </span> <span class="year">(2024)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3390/ijms25084562" target="_blank" href="https://doi.org/10.3390/ijms25084562"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001210368300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001210368300001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85191634590" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85191634590"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38674148" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38674148&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Organic Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Spectroscopy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Computer Science Applications&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Inorganic Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Physical and Theoretical Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Catalysis&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 5</span> | Független: 5 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 4 | Scopus jelölt:&nbsp;4 | WoS/Scopus jelölt:&nbsp;4 | DOI jelölt:&nbsp;5 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34824221&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 34824221</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Human Microbiota Study Group(0272) </div> <div class="lastModified">Utolsó módosítás: 2026.06.10. 11:36 Gere Tamásné (SE_KK_Admin5_GT, admin) </div> </div></div>